In Vitro/In Vivo: Blood - based Biomarkers of Obesity-induce Breast Inflammation

体外/体内：肥胖引起的乳腺炎症的血液生物标志物

• 批准号: 8563993
• 金额: $ 64.4万
• 依托单位: WEILL MEDICAL COLL OF CORNELL UNIV
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-20 至 2014-09-19
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8563993
• 关键词: Age; Algorithms; BRCA1 gene; Biological Markers; Blood; Breast; C-reactive protein; Clinical; Contractor; Data; Development; Diagnosis; Fasting; Formalin; Future; Glucose; Goals; Height; High Density Lipoprotein Cholesterol; Immunohistochemistry; In Vitro; Individual; Inflammation; Insulin; Insulin-Like Growth Factor I; Interleukin-6; Intervention Studies; LDL Cholesterol Lipoproteins; Leptin; Lipids; Mammary Gland Parenchyma; Measurement; Measures; Mutation; Obesity; Paraffin Embedding; Pathologic; Pharmaceutical Preparations; Plasma; Race; Recording of previous events; Reporting; Risk; Stratification; Tissue Sample; Triglycerides; Weight; Woman; adiponectin; base; in vivo; indexing; metabolomics; minimally invasive

The goal of this task order is to develop blood-based biomarkers of obesity-induced breast inflammation to facilitate the development of clinically feasible surrogate biomarkers for risk stratification and future intervention studies.

该任务顺序的目的是开发肥胖引起的乳腺炎症的基于血液的生物标志物，以促进临床上可行的替代生物标志物的发展，以进行风险分层和未来的干预研究。